Post-COVID-19 Syndrome
68
7
11
38
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.9%
2 terminated out of 68 trials
95.0%
+8.5% vs benchmark
4%
3 trials in Phase 3/4
5%
2 of 38 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 38 completed trials
Clinical Trials (68)
Methylprednisolone in Patients With Cognitive Deficits in Post-COVID-19 Syndrome (PCS)
Physical Functions and Lifestyle Behaviours in Post-COVID-19 Syndrome Based on Circadian Rhythms
Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments
Cognitive Rehabilitation in Post-COVID-19 Syndrome
Psychosomatic, Physical Activity or Both for Post-covid19 Syndrom
Balance Acceptance and Commitment Therapy for Long COVID
Rehabilitation of Fatigue in Patients With Post-COVID-19 Syndrome
Transcranial Pulse Stimulation (TPS) in Post-COVID-19
Complementary Self-help Strategies for Patients With Post-COVID-19 Syndrome
Visualizing Regional Lung Ventilation in Patients With Postacute-COVID-19
Effects of Rehabilitation Combined With a Maintenance Program Compared to Rehabilitation Alone in Post-COVID-19
Pursuing Reduction in Fatigue After COVID-19 Via Exercise and Rehabilitation (PREFACER): A Randomized Feasibility Trial
Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome
Yoga Versus Health Education for the Treatment of Persistent Fatigue in Patients With Post COVID-19 Syndrome
Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19
Home-Based Respiratory Muscle Strength Training Program for Individuals With Post-COVID-19 Persistent Dyspnea
Prednisolone and Vitamin B1/6/12 in Patients With Post-Covid-Syndrome
Feasibility of a Well-being Promotion Self-management Intervention in Post-COVID-19 Patients
Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID
Post-COVID-19 Chronic Fatigue Syndrome